Ludger R.
- Country
- Germany
- Department
- NA
Research Overview
- A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
- Efficacy and Safety of Zenagamtide in Participants with Overweight or Obesity and Obstructive Sleep Apnea Treated with Positive Airway Pressure Therapy
- Efficacy and Safety of NNC0487-0111 in Participants with Overweight or Obesity and Obstructive Sleep Apnoea Not Treated with Positive Airway Pressure
Data & Insights
Has run more than one trial at 607 of 1343 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in conducting research on Type 2 Diabetes Mellitus and its treatment approaches, with particular focus on innovative therapeutic solutions including weekly insulin alternatives and glycemic control optimization.
- Novel insulin formulations
- Glycemic control interventions
- Diabetes medication transitions
Additional expertise extends to studying diabetic retinopathy and its progression in relation to diabetes treatments.
Weight Management
Focused on therapeutic approaches for obesity and overweight conditions, investigating novel pharmaceutical interventions for weight reduction in diverse patient populations.
- Weight loss medications
- Obesity-related complications
- Combined therapy approaches
Special attention to weight management in patients with concurrent metabolic conditions.
Comorbid Conditions
Investigates the intersection of multiple health conditions, particularly focusing on chronic kidney disease and obstructive sleep apnea in relation to metabolic disorders.
- Cardiovascular outcomes
- Renal function studies
- Sleep disorder management
Emphasis on comprehensive treatment approaches for patients with multiple health conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.